← Back
Data updated: Mar 10, 2026
AM THERAP
CardiovascularInfectious DiseaseRespiratory
AM THERAP is a generic drug manufacturer focused on Cardiovascular, Infectious Disease, Respiratory.
1987
Since
19
Drugs
-
Trials
220
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
TRAZODONE HYDROCHLORIDE 2026-02-09
Labeling
TRAZODONE HYDROCHLORIDE 2026-02-09
Labeling
AMITRIPTYLINE HYDROCHLORIDE 2026-01-09
Labeling
LORAZEPAM 2026-01-05
Labeling
ACETAMINOPHEN AND CODEINE PHOSPHATE 2025-12-22
Labeling
ACETAMINOPHEN AND CODEINE PHOSPHATE 2025-12-22
Labeling
ACETAMINOPHEN AND CODEINE PHOSPHATE 2025-12-22
Labeling
ACETAMINOPHEN AND CODEINE PHOSPHATE 2025-12-22
Labeling
ACETAMINOPHEN AND CODEINE PHOSPHATE 2025-12-22
Labeling
ACETAMINOPHEN AND CODEINE PHOSPHATE 2025-12-22
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 46%
1 drugs
Infectious Disease 23%
0 drugs Phase 2: 1 Phase 1: 1
Respiratory 15%
0 drugs Phase 2: 1
Metabolic 8%
0 drugs Phase 1: 1
Oncology 8%
0 drugs Phase 1: 1
Pipeline Strength Pro
Loading...
Competitors Pro
Merck big-pharma
Oncology, Infectious Disease, Cardiovascular, Metabolic
Johnson & Johnson big-pharma
Oncology, Infectious Disease, Cardiovascular, Metabolic
Sanofi big-pharma
Metabolic, Oncology, Infectious Disease, Respiratory
AstraZeneca big-pharma
Oncology, Respiratory, Cardiovascular, Metabolic
Novartis big-pharma
Oncology, Cardiovascular, Respiratory
Discontinued (15)
TRAZODONE HYDROCHLORIDE AMITRIPTYLINE HYDROCHLORIDE LORAZEPAM ACETAMINOPHEN AND CODEINE PHOSPHATE PREDNISONE CLORAZEPATE DIPOTASSIUM METHOCARBAMOL THIOTHIXENE CLONIDINE HYDROCHLORIDE FENOPROFEN CALCIUM MECLOFENAMATE SODIUM PRAZOSIN HYDROCHLORIDE CYPROHEPTADINE HYDROCHLORIDE MAPROTILINE HYDROCHLORIDE METAPROTERENOL SULFATE
Company Info
- First Approval
- 1987-03-03
- Latest
- 1988-07-14
- Applications
- 55